125 related articles for article (PubMed ID: 32890606)
21. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
[TBL] [Abstract][Full Text] [Related]
22. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
24. Influence of
Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
[TBL] [Abstract][Full Text] [Related]
25. Comments on "Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study".
Elmali A; Yazici G
Cancer Radiother; 2023 May; 27(3):233-234. PubMed ID: 37080854
[No Abstract] [Full Text] [Related]
26. Ocular ultrasound versus MRI in the detection of extrascleral extension in a patient with choroidal melanoma.
Jacobsen BH; Ricks C; Harrie RP
BMC Ophthalmol; 2018 Dec; 18(1):320. PubMed ID: 30541510
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of dosimetric uncertainty caused by MR geometric distortion in MRI-based liver SBRT treatment planning.
Han S; Yin FF; Cai J
J Appl Clin Med Phys; 2019 Feb; 20(2):43-50. PubMed ID: 30697915
[TBL] [Abstract][Full Text] [Related]
28. Automated Treatment Planning System for Uveal Melanomas Treated With Proton Therapy: A Proof-of-Concept Analysis.
Hennings F; Lomax A; Pica A; Weber DC; Hrbacek J
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):724-731. PubMed ID: 29893280
[TBL] [Abstract][Full Text] [Related]
29. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
[TBL] [Abstract][Full Text] [Related]
30. [Contribution of ultrasound biomicroscopy to conservative treatment of anterior uveal melanoma].
Zografos L; Chamot L; Bercher L; Schalenbourg A; Egger E; Gailloud C
Klin Monbl Augenheilkd; 1996 May; 208(5):414-7. PubMed ID: 8766068
[TBL] [Abstract][Full Text] [Related]
31. The value of magnetic resonance imaging in target volume delineation of base of tongue tumours--a study using flexible surface coils.
Ahmed M; Schmidt M; Sohaib A; Kong C; Burke K; Richardson C; Usher M; Brennan S; Riddell A; Davies M; Newbold K; Harrington KJ; Nutting CM
Radiother Oncol; 2010 Feb; 94(2):161-7. PubMed ID: 20096947
[TBL] [Abstract][Full Text] [Related]
32. Does the imaging method have an influence on the measured tumor height in ruthenium plaque therapy of uveal melanoma?
Schueller P; Dogan A; Panke JE; Micke O; Willich N
Strahlenther Onkol; 2005 May; 181(5):320-5. PubMed ID: 15900429
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
[TBL] [Abstract][Full Text] [Related]
34. A noninvasive eye fixation and computer-aided eye monitoring system for linear accelerator-based stereotactic radiotherapy of uveal melanoma.
Bogner J; Petersch B; Georg D; Dieckmann K; Zehetmayer M; Pötter R
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1128-36. PubMed ID: 12829151
[TBL] [Abstract][Full Text] [Related]
35. [Choroidal melanoma stage T1 - comparison of the planning protocol for stereotactic radiosurgery and proton beam irradiation].
Furdová A; Růžička J; Sramka M; Králik G; Chorváth M; Kusenda P
Cesk Slov Oftalmol; 2012 Oct; 68(4):156-61. PubMed ID: 23214488
[TBL] [Abstract][Full Text] [Related]
36. Proton therapy for uveal melanomas and other eye lesions.
Munzenrider JE
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():68-73. PubMed ID: 10394402
[TBL] [Abstract][Full Text] [Related]
37. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
38. [Endoresection following proton beam irradiation of large uveal melanomas].
Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
40. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
